 |
 |


UCSD DISCOVERIES, CREATIONS &
APPLICATIONS
WINTER 2000
- A team of researchers lead by UCSD bioengineer Geert Schmid-Schoenbein
have succeeded in blocking the fundamental mechanism that causes major
organ shutdown following shock. In experiments, the researchers prevented
shock and organ failure in laboratory rats with a drug that blocks digestive
enzymes in the intestines. When a body goes into shock, enzymes normally
used for digestion of food set off a string of chemical reactions that
quickly damage organs. The discovery of this inhibitor drug, which the
researchers will soon begin testing on humans, represents a major breakthrough
that could lead to new life-saving treatments for trauma and other shock
victims.
- Alcohol abuse among adolescents may lead to brain damage, according
to a new UCSD study examining brain function in 15 and 16-year-old adolescents.
The study, directed by psychologist Sandra Brown, found that heavy drinking
during the teen years of 15-16 can cause damage to thinking abilities,
especially memory functions, at a time when certain brain developments
are at a critical stage. Researchers suspect, however, that some of
the damage may be reversible if drinking is curtailed, since adolescent
brains are still developing.
- The AIDS virus may date back to 1930, when it most likely crossed
over from chimpanzees to humans in central West Africa. While some studies
have claimed that HIV spread from contaminated oral polio vaccines used
in the Belgian Congo in the late 1950s, most recently a few researchers,
including UCSD anthropologist Jim Moore, have traced the virus back
to 1930, a time -- under colonial rule -- of great turbulence in Africa,
when people were driven out of their villages and forced to subsist
in a jungle environment, where the butchering and consuming of chimpanzees
was common practice.
- Calendar effects in the stock market are just wishful thinking,
according to a new study lead by UCSD economist Halbert White. While
some investors think there is a "Monday effect" or an "October
effect" in the stock market – some of the largest stock market
crashes have fallen on Mondays, Black Monday in 1927 and the big crash
in 1987, and both crashes occurred in October – White argues that following
these rules will not lead to greater gains for the investor. The study,
which examined stock market patterns over the last century, found that
the "Monday effect" was the most prominent calendar pattern
exhibited, but no real predictable effects exist over time.
- UCSD cardiac researchers have pinpointed a gene that causes a type
of heart failure and, by blocking the gene, have stopped the disease
dead in its tracks. While the research, led by Dr. Ken Chien, was done
on genetically-engineered mice, the discovery could lead to the development
of drugs that block the progression of heart failure, a disease that
affects 3.5 million Americans and is the leading cause of hospitalization
in developed nations. The discovery also opens the door for gene therapy
for prevention of the disease.
- Orthopedic researchers and physicians at the School of Medicine
are working with NASA to examine how micro-gravity, as experienced by
astronauts and by patients in extended bedrest, effects the body. Orthopedics
professor Alan Hargens and a team of researchers are testing a treadmill
"chamber" which simulates changes in gravity, reducing or
adding to a person’s weight, while that person is running. The device
is being evaluated for its potential to enhance rehabilitation after
injury, stroke, surgery, or prolonged inactivity, as well as for athletes
in training.
- Scientists have developed the first mouse model genetically programmed
to simulate motor deficits and brain alterations found in Parkinson’s
disease and related disorders. According to UCSD neuroscientist Eliezer
Masliah, who is leading the project, the development of symptoms in
genetically altered mice resembles disease progression in humans. The
development of the model will shed new light on the role of human protein
in the brain cells of Parkinson’s patients and will be useful in the
development and testing of new drugs for this and related conditions.
|